Results 251 to 260 of about 1,701,603 (284)

Marburg Virus Outbreak in Equatorial Guinea: Need for Speed. [PDF]

Ann Glob Health
Ezie KN, Takoutsing BD, Modeste D, Ines MZ, Sybile TNL, Caleb NM, Esene IN.   +6 more
europepmc   +1 more source

Modified oxymatrine as novel therapeutic inhibitors against Monkeypox and Marburg virus through computational drug design approaches. [PDF]

J Cell Mol Med
Islam MR, Biswas S, Amena U, Rahman M, Islam S, Islam MA, Saleh MA, Hassan HM, Al-Emam A, Zaki MEA.   +9 more
europepmc   +1 more source

Corrigendum to "Rescue and characterization of the first West African Marburg virus 2021 from Guinea" [Heliyon Volume 9, Issue 9, September 2023, e19613]. [PDF]

Heliyon
von Creytz I, Gerresheim GK, Lier C, Schneider J, Schauflinger M, Benz M, Kämper L, Rohde C, Eickmann M, Biedenkopf N.   +9 more
europepmc   +1 more source

Vaccine Platform Comparison: Protective Efficacy against Lethal Marburg Virus Challenge in the Hamster Model. [PDF]

Int J Mol Sci
O'Donnell KL, Henderson CW, Anhalt H, Fusco J, Erasmus JH, Lambe T, Marzi A.   +6 more
europepmc   +1 more source

Longitudinal proteome-wide antibody profiling in Marburg virus survivors identifies wing domain immunogen for vaccine design. [PDF]

Nat Commun
Khurana S, Grubbs G, Ravichandran S, Cluff E, Kim J, Kuehne AI, Zak S, Dye JM, Lutwama JJ, Herbert AS.   +9 more
europepmc   +1 more source

Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in Humans. [PDF]

Vaccines (Basel)
Tscherne A, Kalodimou G, Kupke A, Rohde C, Freudenstein A, Jany S, Kumar S, Sutter G, Krähling V, Becker S, Volz A.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Marburg Virus Disease in Ghana.

New England Journal of Medicine, 2023
J. Bonney, Bright Adu, Terrel Sanders, D. Pratt, P. Adams, I. Asante, E. Bonney, Bright Agbodzi, Selassie Kumordjie, Martin Faye, E. Obodai, Prince Ketorwoley, Clara Yeboah, Mildred Tublu, M. Diagne, A. Diallo, M. Ofori, D. Laryea, F. Asiedu-Bekoe, G. Kyei, S. Ohene, G. Boateng, R. Chapman, O. Faye, Michael Wiley, J. Odoom, A. Sall, F. Kasolo, D. Yeboah-Manu   +28 more
semanticscholar   +3 more sources

A highly attenuated pan-filovirus VesiculoVax vaccine rapidly protects nonhuman primates against Marburg virus and three species of Ebolavirus.

Journal of Infectious Diseases, 2023
BACKGROUND The family Filoviridae consists of several virus members known to cause significant mortality and disease in humans. Among these, Ebola virus (EBOV), Marburg virus (MARV), Sudan virus (SUDV), and Bundibugyo virus (BDBV) are considered the ...
Courtney Woolsey, V. Borisevich, K. Agans, Rachel O'Toole, Karla A. Fenton, Mack B Harrison, A. Prasad, D. Deer, Cheryl S. Gerardi, Nneka Morrison, R. Cross, J. Eldridge, Demetrius Matassov, T. Geisbert   +13 more
semanticscholar   +1 more source

Marburg Virus- A threat during SARS-CoV-2 era: A Review.

Infectious Diseases - Drug Targets, 2023
In the German towns of Marburg, Frankfurt, and Belgrade in 1967, this single negative-stranded RNA virus was initially discovered. The importation of infected grivet monkeys from Uganda is what caused this virus-related sickness. As a result of the early
Sumel Ashique, Vatan Chaudhary, S. Pal, Jonee Panwar, Mukesh Kumar, Soumi Pramanik, Abhipsa Sinha, Anagh Mukherjee   +7 more
semanticscholar   +1 more source